Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 16 studies | 50% ± 18% | |
oligodendrocyte precursor cell | 9 studies | 37% ± 16% | |
GABAergic neuron | 6 studies | 40% ± 17% | |
glutamatergic neuron | 6 studies | 41% ± 24% | |
astrocyte | 6 studies | 29% ± 9% | |
endothelial cell | 3 studies | 26% ± 8% | |
interneuron | 3 studies | 47% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 12 studies | 34% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 3082.72 | 2640 / 2642 | 100% | 63.58 | 704 / 705 |
thymus | 93% | 692.16 | 608 / 653 | 61% | 5.33 | 372 / 605 |
adrenal gland | 95% | 880.77 | 244 / 258 | 58% | 17.28 | 134 / 230 |
prostate | 90% | 991.58 | 221 / 245 | 34% | 1.81 | 172 / 502 |
lung | 96% | 938.51 | 554 / 578 | 27% | 3.50 | 314 / 1155 |
pancreas | 61% | 247.22 | 199 / 328 | 45% | 4.49 | 80 / 178 |
heart | 97% | 1411.34 | 833 / 861 | 0% | 0 | 0 / 0 |
skin | 4% | 13.11 | 72 / 1809 | 81% | 14.27 | 384 / 472 |
muscle | 84% | 711.62 | 671 / 803 | 0% | 0 | 0 / 0 |
esophagus | 54% | 405.02 | 783 / 1445 | 25% | 2.71 | 46 / 183 |
intestine | 62% | 589.55 | 596 / 966 | 13% | 2.26 | 69 / 527 |
uterus | 58% | 310.34 | 99 / 170 | 15% | 2.14 | 70 / 459 |
bladder | 62% | 398.48 | 13 / 21 | 8% | 1.00 | 42 / 504 |
blood vessel | 52% | 338.47 | 697 / 1335 | 0% | 0 | 0 / 0 |
stomach | 32% | 205.03 | 116 / 359 | 20% | 2.59 | 56 / 286 |
ovary | 35% | 256.04 | 63 / 180 | 7% | 0.41 | 30 / 430 |
breast | 28% | 124.77 | 127 / 459 | 5% | 0.38 | 60 / 1118 |
adipose | 32% | 191.35 | 387 / 1204 | 0% | 0 | 0 / 0 |
kidney | 21% | 67.62 | 19 / 89 | 6% | 0.56 | 55 / 901 |
eye | 0% | 0 | 0 / 0 | 21% | 1.60 | 17 / 80 |
peripheral blood | 13% | 64.21 | 121 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.39 | 3 / 45 |
liver | 0% | 0 | 0 / 226 | 6% | 3.32 | 23 / 406 |
spleen | 4% | 15.19 | 10 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030199 | Biological process | collagen fibril organization |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0050211 | Molecular function | procollagen galactosyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | COLGALT2 |
Protein name | Procollagen galactosyltransferase 2 (EC 2.4.1.50) (Collagen beta(1-O)galactosyltransferase 2) (ColGalT 2) (Glycosyltransferase 25 family member 2) (Hydroxylysine galactosyltransferase 2) Collagen beta(1-O)galactosyltransferase 2 |
Synonyms | KIAA0584 C1orf17 GLT25D2 |
Description | FUNCTION: Beta-galactosyltransferase that transfers beta-galactose to hydroxylysine residues of collagen. . |
Accessions | ENST00000649786.1 Q8IYK4 A0A3B3IT37 ENST00000367520.3 Q5SXQ3 ENST00000361927.9 ENST00000367521.5 Q5SXQ5 |